Inferra AIResearch Tools

Inferra AI / Company / CRON

Cronos Group

CRON · Health Care

Last earnings Oct 15, 2026

AI analysis

Q2 2026 · reported Oct 15, 2026

Based on: Earnings release + parent 8-K — transcript not held

No extracted figures held

The event-summary record for this company carries no extracted figures, so the brief and charts cannot be drawn yet. The summary below and the held documents are the record for this event.

Guidance · company-stated

No guidance located in the held release

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

In some cases, Forward-looking 12 Base purchase price refers to the 57.5 million base amount before closing and post-closing adjustments including adjustments for CanAdelaar s net debt position.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

The base purchase price represents approximately 1.4x CanAdelaar net revenue and 2.9x CanAdelaar Adjusted EBITDA based on 1H 2026 annualized results

Based on: Earnings release + parent 8-K — transcript not held

Guidance & outlook

No guidance located in the held release

Capital allocation

In some cases, Forward-looking 12 Base purchase price refers to the 57.5 million base amount before closing and post-closing adjustments including adjustments for CanAdelaar s net debt position.

SEC original ↗Cronos Group — Earnings release (8-K exhibit)EX-99Oct 15, 2026

Strategy & priorities

htm EX-99.1 Document Cronos Completes Acquisition of CanAdelaar, Europe s Largest Adult-Use Cannabis Company Cronos acquires CanAdelaar for a base purchase price of 57.5 million plus cash earnout of 0.5x Normalized EBITDA 1 in 2026 and 2027 Establishes Cronos European platform with #1 market share 2 in the largest adult-use cannabis market in Europe 3 Enables borderless product strategy, leveraging investments in genetics, R D, and product development TORONTO, October 15, 2026 (GLOBE NEWSWIRE) Cronos Group Inc.

SEC original ↗Cronos Group — Earnings release (8-K exhibit)EX-99Oct 15, 2026

We are excited to welcome the CanAdelaar team to Cronos and accelerate execution of our borderless product strategy in the Netherlands.

SEC original ↗Cronos Group — Earnings release (8-K exhibit)EX-99Oct 15, 2026

The completion of the acquisition positions Cronos as the leader in the Wietexperiment , Europe s largest adult-use cannabis market, establishes a European operating platform for Cronos borderless product strategy, and provides Cronos a role in a thoughtfully designed regulatory framework for adult-use cannabis.

SEC original ↗Cronos Group — Earnings release (8-K exhibit)EX-99Oct 15, 2026

Cronos expects a smooth integration and will continue to focus on regulatory compliance, operational excellence, and responsible adult-use cannabis consumption.

SEC original ↗Cronos Group — Earnings release (8-K exhibit)EX-99Oct 15, 2026

Strategic Rationale The acquisition is expected to provide strategic and financial benefits that will further Cronos position as a leading global cannabis company, including Enabling Borderless Product Strategy a platform to bring Cronos investments in genetic breeding, product development and brand portfolio to Dutch adult-use consumers.

SEC original ↗Cronos Group — Earnings release (8-K exhibit)EX-99Oct 15, 2026

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Gilead Sciences (GILD) Health CareGenmab (GMAB) Health CareAlcon (ALC) Health CareArgenx (ARGX) Health CareSanofi (SNY) Health CareMerck & Co. (MRK) Health CareXencor Inc (XNCR) Health CareIllumina, Inc. (ILMN) Health Care
Documents

Filings

30 documents

Earnings releases

3 documents

Presentations

0 documents

No presentations for Cronos Group are held in this edition of the library.

Transcripts

0 documents

No transcripts for Cronos Group are held in this edition of the library.

Mentioned by

4 companies

Other tracked companies whose held documents mention Cronos Group by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.